Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-947"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20101124.15.3-947"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"I voted in favour of the proposal for a regulation of the European Parliament and of the Council on amending, as regards information to the general public on medicinal products for human use subject to medical prescription, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency so that it will guarantee in future a legal EU framework enabling European citizens to have equal access to correct and clear information about medicinal products.
The report presented by the Commission on 20 December 2007 concerning ‘current practices with regard to the provision of information to patients on medicinal products’ indicates that Member States have adopted divergent rules and practices with regard to the provision of information on medicinal products, resulting in a situation where patients and the general public have unequal access to this information. Europe’s citizens are entitled to have access to correct and clear information about medicinal products. I think that it is important that the regulation safeguards the interests of patients and ensures that the latest communication media are used to provide the general public with information that is correct, accessible and easy to understand, in a transparent way, independently of the commercial interests of the pharmaceutical companies."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples